期刊文献+

口服5-羟色胺-3受体拮抗药预防化疗引起的呕吐 被引量:7

Oral administration of 5-HT_3 receptor antagonists for prevention of acute emesis associated with chemotherapy
下载PDF
导出
摘要 口服 5 羟色胺 3(5 HT3 )受体拮抗药用于细胞毒药物和其他致吐物质引起的外周反射性呕吐有明显疗效 ,其吸收迅速 ,对 5 HT3 受体有较强亲合力。预防强致吐物引起的呕吐 ,可口服格拉司琼2mg·d- 1或昂丹司琼 2 4mg·d- 1;预防中度致吐物引起的呕吐 ,可采用格拉司琼 1mg·d- 1,或昂丹司琼 8mg ,bid ,或多拉司琼 10 0mg·d- 1。 There were remarkable effect and rapid absorption, and stronger affinity for 5-HT 3 receptor by oral administration of 5-HT 3 receptor antagonists for peripheral reflected vomiting induced by cytotoxic drugs and other vomiting-induced substances. The vomiting induced by strong vomiting-induced substances could be prevented by oral administration of granisetron 2 mg, qd or ondansestron 24 mg, qd. The vomiting induced by moderate vomiting-induced substances could be prevented by oral administration of granisetron 1 mg, qd, ondansetron 8 mg, bid or dolasetron 100 mg, qd.
作者 李性天
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2002年第11期672-675,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 5-羟色胺-3受体拮抗药 预防 化疗 呕吐 格拉司琼 昂丹司琼 多拉司琼 granisetron ondansetron dolasetron drug therapy vomiting antiemetics
  • 相关文献

参考文献15

  • 1RUBENSTEIN EB, GRALLA RJ, HAINSWORTH JD, et al. Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy[J]. Cancer, 1997,79(4):1216-1224.
  • 2BLEIBERG HH, SPIELMANN M, FALKSON G, et al. Antiemetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy: a dose-ranging study[J]. Clin Ther, 1995,17(2):238-251.
  • 3ETTINGER DS, ELSENBERG PD, FITTS D, et al. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy[J]. Cancer, 1996,78(1):144-151.
  • 4BURRIS H, HESKETH P, COHN J, et al. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy[J]. Cancer J Sci Am, 1996,2(1):85-90.
  • 5HERON JF, GOEDHALS L, JORDAAN JP, et al. Oral granisetron alone and in combination with dexamethasone[J]. Ann Oncol, 1994,5:579-584.
  • 6GRALLA RJ, NAVARI RM, HESKETH PJ, et al. Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy[J]. J Clin Oncol, 1998,16(5):1568-1573.
  • 7PEREZ EA, HESKETH P, SANDBACH J, et al. Comparison of single-dose oral granisetron and intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy[J]. J Clin Oncol, 1998, 16(3):754-760.
  • 8MARKMAN M, KENNEDY A, WEBSTER K, et al. Low-dose oral granisetron (1 mg) plus intravenous dexamethaxone: efficacy in gynecologic cancer patients receiving carboplatin-based chemotherapy[J]. Gynecol Oncol, 1998, 71(1):113-115.
  • 9王更利,尹绪德,姚文秀,傅彬玉,王谊.昂丹司琼和甲氧氯普胺在肿瘤化学疗法时作为止吐剂的对比[J].新药与临床,1994,13(6):350-352. 被引量:2
  • 10KRZAKOWSKI M, GRAHAM E, GOEDHALS L, et al. A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethaxone for acute cisplatin-induced emesis[J]. Anticacer Drugs, 1998,9(3):593-598.

共引文献1

同被引文献42

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部